31 research outputs found
Structural features governing the activity of lactoferricin-derived peptides that act in synergy with antibiotics against Pseudomonas aeruginosa in vitro and in vivo
Pseudomonas aeruginosa is naturally resistant to many antibiotics, and infections caused by this organism are a serious threat, especially to hospitalized patients. The intrinsic low permeability of P. aeruginosa to antibiotics results from the coordinated action of several mechanisms, such as the presence of restrictive porins and the expression of multidrug efflux pump systems. Our goal was to develop antimicrobial peptides with an improved bacterial membrane-permeabilizing ability, so that they enhance the antibacterial activity of antibiotics. We carried out a structure activity relationship analysis to investigate the parameters that govern the permeabilizing activity of short (8- to 12-amino-acid) lactoferricin-derived peptides. We used a new class of constitutional and sequence-dependent descriptors called PEDES (peptide descriptors from sequence) that allowed us to predict (Spearman's ρ = 0.74; P < 0.001) the permeabilizing activity of a new peptide generation. To study if peptide-mediated permeabilization could neutralize antibiotic resistance mechanisms, the most potent peptides were combined with antibiotics, and the antimicrobial activities of the combinations were determined on P. aeruginosa strains whose mechanisms of resistance to those antibiotics had been previously characterized. A subinhibitory concentration of compound P2-15 or P2-27 sensitized P. aeruginosa to most classes of antibiotics tested and counteracted several mechanisms of antibiotic resistance, including loss of the OprD porin and overexpression of several multidrug efflux pump systems. Using a mouse model of lethal infection, we demonstrated that whereas P2-15 and erythromycin were unable to protect mice when administered separately, concomitant administration of the compounds afforded long-lasting protection to one-third of the animals
Substrate specificity of a peptidyl-aminoacyl-l/d-isomerase from frog skin
In the skin of fire-bellied toads (Bombina species), an aminoacyl-l/d-isomerase activity is present which catalyses the post-translational isomerization of the l- to the d-form of the second residue of its substrate peptides. Previously, this new type of enzyme was studied in some detail and genes potentially coding for similar polypeptides were found to exist in several vertebrate species including man. Here, we present our studies to the substrate specificity of this isomerase using fluorescence-labeled variants of the natural substrate bombinin H with different amino acids at positions 1, 2 or 3. Surprisingly, this enzyme has a rather low selectivity for residues at position 2 where the change of chirality at the alpha-carbon takes place. In contrast, a hydrophobic amino acid at position 1 and a small one at position 3 of the substrate are essential. Interestingly, some peptides containing a Phe at position 3 also were substrates. Furthermore, we investigated the role of the amino-terminus for substrate recognition. In view of the rather broad specificity of the frog isomerase, we made a databank search for potential substrates of such an enzyme. Indeed, numerous peptides of amphibia and mammals were found which fulfill the requirements determined in this study. Expression of isomerases with similar characteristics in other species can therefore be expected to catalyze the formation of peptides containing d-amino acids
Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome : Insights from the LUNG SAFE study
Publisher Copyright: © 2020 The Author(s). Copyright: Copyright 2020 Elsevier B.V., All rights reserved.Background: Concerns exist regarding the prevalence and impact of unnecessary oxygen use in patients with acute respiratory distress syndrome (ARDS). We examined this issue in patients with ARDS enrolled in the Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG SAFE) study. Methods: In this secondary analysis of the LUNG SAFE study, we wished to determine the prevalence and the outcomes associated with hyperoxemia on day 1, sustained hyperoxemia, and excessive oxygen use in patients with early ARDS. Patients who fulfilled criteria of ARDS on day 1 and day 2 of acute hypoxemic respiratory failure were categorized based on the presence of hyperoxemia (PaO2 > 100 mmHg) on day 1, sustained (i.e., present on day 1 and day 2) hyperoxemia, or excessive oxygen use (FIO2 ≥ 0.60 during hyperoxemia). Results: Of 2005 patients that met the inclusion criteria, 131 (6.5%) were hypoxemic (PaO2 < 55 mmHg), 607 (30%) had hyperoxemia on day 1, and 250 (12%) had sustained hyperoxemia. Excess FIO2 use occurred in 400 (66%) out of 607 patients with hyperoxemia. Excess FIO2 use decreased from day 1 to day 2 of ARDS, with most hyperoxemic patients on day 2 receiving relatively low FIO2. Multivariate analyses found no independent relationship between day 1 hyperoxemia, sustained hyperoxemia, or excess FIO2 use and adverse clinical outcomes. Mortality was 42% in patients with excess FIO2 use, compared to 39% in a propensity-matched sample of normoxemic (PaO2 55-100 mmHg) patients (P = 0.47). Conclusions: Hyperoxemia and excess oxygen use are both prevalent in early ARDS but are most often non-sustained. No relationship was found between hyperoxemia or excessive oxygen use and patient outcome in this cohort. Trial registration: LUNG-SAFE is registered with ClinicalTrials.gov, NCT02010073publishersversionPeer reviewe
Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine
Scanning densitometric and calorimetric studies of poly (Ethylene oxide) Poly(Propylene oxide) Poly(Ethylene oxide) Triblock copolymers (Poloxamers) in dilute aqueous-solution
The phase transition properties of poloxamers, in dilute aqueous solution (1 % w/v), detected by high-sensitivity differential scanning calorimetry (HSDSC) and differential scanning densitometry (DSD) at a scan rate of 30 K h-1 are reported. Poloxamers are ABA block copolymers of poly(oxyethylene) (A) and poly(oxypropylene) (B). The molecular weights of the poloxamers examined range from 2400 to 14000. The solutions are transparent over the temperature range of the observed phase transition. By HSDSC, the temperatures (T(m)) at which the differential excess heat capacity (C(p,m)) is a maximum range from 297 to 313 K and show good agreement with T(m) values obtained by DSD. The observed T(m) values decrease with increasing poly(oxypropylene) content. The calorimetric enthalpy (DELTAH(cal) of the phase transitions, which range from 133 to 337 kJ mol-1, increases with increasing poly(oxypropylene) content. The partial specific volume changes (DELTAvBAR)) of the phase transitions range from 5.6 x 10(-3) to 6.2 x 10(-2) cm3 g-1. The experimentally determined partial specific volumes (vBAR) for the poloxamers in dilute aqueous solution, at temperatures below the phase transition, agree reasonably well with those calculated for beta and gamma lattice structure forms (orthorhombic perpendicular or monoclinic lattice, respectively). At temperatures above the T(m), experimental vBAR values agree more closely with those calculated for the theoretical a form of hexagonally packed chains based on alkanols, characteristic of the more expanded form. The DSD data are discussed in terms of partial molal volume (V2(0)BAR) and expansibility (E2(0)BAR) at inifinte dilution in water. Both parameters show a dependence on temperature. This suggests that the poloxamers undergo a gradual change in molecular size as a function of temperature, possibly accompanied by a rapid conformational change around the observed T(m). Cooperativity values (DELTAH(vH)/DELTAH(cal)) of the phase transitions from HSDSC data are between 1.2 and 2.8; this together with the asymmetry of the transitions is indicative of an aggregation process. The relationships between DELTAV2(0)BAR and DELTAH(cal) per average monomer unit vs poly(oxypropylene) (POP)/poly(oxyethylene) (POE) ratio indicate that the observed phase transition is associated with the POP portion of the polymer, as both parameters approach zero as the POP/POE ratio approaches 0:1. The observed phase transitions are reversible and are unaffected by scan rate (10, 30 and 60 K h-1) using both techniques and hence show no kinetic limitations. The parameters derived from HSDSC and DSD data for the poloxamers are analyzed in terms of possible microscopic and macroscopic phenomena occurring during the phase transitions
Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide
Antibacterial peptide acylation, which mimics the structure of the natural lipopeptide polymyxin B, increases antimicrobial and endotoxin-neutralizing activities. The interaction of the lactoferricin-derived peptide LF11 and its N-terminally acylated analogue, lauryl-LF11, with different chemotypes of bacterial lipopolysaccharide (LPS Re, Ra and smooth S form) was investigated by biophysical means and was related to the peptides' biological activities. Both peptides exhibit high antibacterial activity against the three strains of Salmonella enterica differing in the LPS chemotype. Lauryl-LF11 has one order of magnitude higher activity against Re-type, but activity against Ra- and S-type bacteria is comparable with that of LF11. The alkyl derivative peptide lauryl-LF11 shows a much stronger inhibition of the LPS-induced cytokine induction in human mononuclear cells than LF11. Although peptide-LPS interaction is essentially of electrostatic nature, the lauryl-modified peptide displays a strong hydrophobic component. Such a feature might then explain the fact that saturation of the peptide binding takes place at a much lower peptide/LPS ratio for LF11 than for lauryl-LF11, and that an overcompensation of the negative LPS backbone charges is observed for lauryl-LF11. The influence of LF11 on the gel-to-liquid-crystalline phase-transition of LPS is negligible for LPS Re, but clearly fluidizing for LPS Ra. In contrast, lauryl-LF11 causes a cholesterol-like effect in the two chemotypes, fluidizing in the gel and rigidifying of the hydrocarbon chains in the liquid-crystalline phase. Both peptides convert the mixed unilamellar/non-lamellar aggregate structure of lipid A, the 'endotoxic principle' of LPS, into a multilamellar one. These data contribute to the understanding of the mechanisms of the peptide-mediated neutralization of endotoxin and effect of lipid modification of peptides
Comparative analysis of selected methods for the assessment of antimicrobial and membrane-permeabilizing activity: a case study for lactoferricin derived peptides
Growing concerns about bacterial resistance to antibiotics have
prompted the development of alternative therapies like those based on cationic
antimicrobial peptides (APs). These compounds not only are bactericidal by
themselves but also enhance the activity of antibiotics. Studies focused on the
systematic characterization of APs are hampered by the lack of standard
guidelines for testing these compounds. We investigated whether the information
provided by methods commonly used for the biological characterization of APs is
comparable, as it is often assumed. For this purpose, we determined the
bacteriostatic, bactericidal, and permeability-increasing activity of synthetic
peptides (n = 57; 9-13 amino acid residues in length) analogous to the
lipopolysaccharide-binding region of human lactoferricin by a number of the most
frequently used methods and carried out a comparative analysis. RESULTS: While
the minimum inhibitory concentration determined by an automated
turbidimetry-based system (Bioscreen) or by conventional broth microdilution
methods did not differ significantly, bactericidal activity measured under static
conditions in a low-ionic strength solvent resulted in a vast overestimation of
antimicrobial activity. Under these conditions the degree of antagonism between
the peptides and the divalent cations differed greatly depending on the bacterial
strain tested. In contrast, the bioactivity of peptides was not affected by the
type of plasticware (polypropylene vs. polystyrene). Susceptibility testing of
APs using cation adjusted Mueller-Hinton was the most stringent screening method,
although it may overlook potentially interesting peptides. Permeability assays
based on sensitization to hydrophobic antibiotics provided overall information
analogous - though not quantitatively comparable- to that of tests based on the
uptake of hydrophobic fluorescent probes. CONCLUSION: We demonstrate that subtle
changes in methods for testing cationic peptides bring about marked differences
in activity. Our results show that careful selection of the test strains for
susceptibility testing and for screenings of antibiotic-sensitizing activity is
of critical importance. A number of peptides proved to have potent
permeability-increasing activity at subinhibitory concentrations and efficiently
sensitized Pseudomonas aeruginosa both to hydrophilic and hydrophobic
antibiotics
Structural features governing the activity of lactoferricin-derived peptides that act in synergy with antibiotics against Pseudomonas aeruginosa in vitro and in vivo
Pseudomonas aeruginosa is naturally resistant to many antibiotics, and infections caused by this organism are a serious threat, especially to hospitalized patients. The intrinsic low permeability of P. aeruginosa to antibiotics results from the coordinated action of several mechanisms, such as the presence of restrictive porins and the expression of multidrug efflux pump systems. Our goal was to develop antimicrobial peptides with an improved bacterial membrane-permeabilizing ability, so that they enhance the antibacterial activity of antibiotics. We carried out a structure activity relationship analysis to investigate the parameters that govern the permeabilizing activity of short (8- to 12-amino-acid) lactoferricin-derived peptides. We used a new class of constitutional and sequence-dependent descriptors called PEDES (peptide descriptors from sequence) that allowed us to predict (Spearman's ρ = 0.74; P < 0.001) the permeabilizing activity of a new peptide generation. To study if peptide-mediated permeabilization could neutralize antibiotic resistance mechanisms, the most potent peptides were combined with antibiotics, and the antimicrobial activities of the combinations were determined on P. aeruginosa strains whose mechanisms of resistance to those antibiotics had been previously characterized. A subinhibitory concentration of compound P2-15 or P2-27 sensitized P. aeruginosa to most classes of antibiotics tested and counteracted several mechanisms of antibiotic resistance, including loss of the OprD porin and overexpression of several multidrug efflux pump systems. Using a mouse model of lethal infection, we demonstrated that whereas P2-15 and erythromycin were unable to protect mice when administered separately, concomitant administration of the compounds afforded long-lasting protection to one-third of the animals
The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms
Development of novel antimicrobial agents is a top priority in the fight against multidrug-resistant (MDR) and persistent bacteria. We developed a panel of synthetic antimicrobial and antibiofilm peptides (SAAPs) with enhanced antimicrobial activities compared to the parent peptide, human antimicrobial peptide LL-37. Our lead peptide SAAP-148 was more efficient in killing bacteria under physiological conditions in vitro than many known preclinical-and clinical-phase antimicrobial peptides. SAAP-148 killed MDR pathogens without inducing resistance, prevented biofilm formation, and eliminated established biofilms and persister cells. A single 4-hour treatment with hypromellose ointment containing SAAP-148 completely eradicated acute and established, biofilm-associated infections with methicillin-resistant Staphylococcus aureus and MDR Acinetobacter baumannii from wounded ex vivo human skin and murine skin in vivo. Together, these data demonstrate that SAAP-148 is a promising drug candidate in the battle against antibiotic-resistant bacteria that pose a great threat to human healt